Related Experiment Video
Updated: Aug 6, 2025

Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
iPSC-sEVs alleviate microglia senescence to protect against ischemic stroke in aged mice
Xinyu Niu1, Yuguo Xia2, Lei Luo3
1Department of Neurosurgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Abstract:
The polarization of microglia plays an important role in the outcome of ischemic stroke (IS). In the aged population, senescent microglia show a predominant pro-inflammatory phenotype, which leads to worse outcomes in aged ischemic stroke compared to young ischemic stroke. Recent research demonstrated that inducible pluripotent stem cell-derived small extracellular vesicles (iPSC-sEVs) possess the significant anti-ageing ability. We hypothesized that iPSC-sEVs could alleviate microglia senescence to regulate microglia polarization in aged ischemic stroke. In this study, we showed that treatment with iPSC-sEVs significantly alleviated microglia senescence as indicated by the decreased senescence-associated proteins including P16, P21, P53, and γ-H2AX as well as the activity of SA-β-gal, and inhibited pro-inflammatory activation of microglia both in vivo and in vitro. Furthermore, iPSC-sEVs shifted microglia from pro-inflammatory phenotype to anti-inflammatory phenotype, which reduced the apoptosis of neurons, and improved the outcome of aged stroke mice. Mechanism studies showed that iPSC-sEVs reversed the loss of Rictor and downstream p-AKT (s473) in senescent microglia, which was involved in the senescence and pro-inflammatory phenotype regulation of microglia. Inhibition of Rictor abolished the iPSC-sEVs-afforded phosphorylation of AKT and alleviation of inflammation of senescent microglia. Proteomics results indicated that iPSC-sEVs carried transforming growth factor-β1 (TGF-β1) to upregulate Rictor and p-AKT in senescent microglia, which could be hindered by blocking TGF-β1. Taken together, our work demonstrates iPSC-sEVs reverse the senescent characteristic of microglia in aged brains and therefore improve the outcome after stroke, at least, via delivering TGF-β1 to upregulate Rictor and p-AKT. Our data suggest that iPSC-sEVs might be a novelty therapeutic method for aged ischemic stroke and other diseases involving senescent microglia.
Insights
Inducible pluripotent stem cell-derived small extracellular vesicles (iPSC-sEVs) reverse microglia aging in stroke. This therapy reduces inflammation and improves outcomes in aged mice, offering a novel treatment for aged ischemic stroke.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cellular Biology
Background:
- Microglia polarization significantly impacts ischemic stroke (IS) outcomes.
- Senescent microglia in aged individuals exhibit a pro-inflammatory phenotype, worsening IS outcomes.
- Inducible pluripotent stem cell-derived small extracellular vesicles (iPSC-sEVs) demonstrate anti-aging properties.
Purpose of the Study:
- To investigate if iPSC-sEVs can alleviate microglia senescence and modulate polarization in aged ischemic stroke.
- To explore the therapeutic potential of iPSC-sEVs for aged ischemic stroke.
Main Methods:
- Treatment of aged mice and cell cultures with iPSC-sEVs.
- Assessment of microglia senescence markers (P16, P21, P53, γ-H2AX, SA-β-gal activity).
- Analysis of microglia polarization (pro-inflammatory vs. anti-inflammatory phenotypes).
- Investigation of the Rictor/AKT signaling pathway and transforming growth factor-β1 (TGF-β1) involvement.
- Evaluation of neuronal apoptosis and stroke outcomes in mice.
Main Results:
- iPSC-sEV treatment significantly reduced microglia senescence markers and inhibited pro-inflammatory activation.
- iPSC-sEVs shifted microglia polarization towards an anti-inflammatory phenotype, decreasing neuronal apoptosis.
- The therapy improved outcomes in aged stroke mice by upregulating Rictor and p-AKT (s473) via TGF-β1 delivery.
- Inhibition of Rictor abolished the beneficial effects of iPSC-sEVs on microglia.
Conclusions:
- iPSC-sEVs effectively reverse microglia senescence and pro-inflammatory characteristics in aged brains.
- The therapeutic mechanism involves TGF-β1 delivery by iPSC-sEVs to upregulate Rictor and p-AKT signaling.
- iPSC-sEVs represent a promising therapeutic strategy for aged ischemic stroke and related conditions.
More Related Videos
Related Concept Videos
iPS Cell Differentiation
EPS and iPS Cells in Disease Research

